Search for stocks /

Tarsons Products Ltd Q1 FY26 – Labware King with 1,700 SKUs, P/E 60, Profit Drop -55%: Pipettes Are Sexy, Margins Are Not


1. At a Glance

Tarsons Products Ltd is India’s answer to “What if Tupperware went to Harvard Medical School?” With 1,700+ SKUs ranging from pipette tips to cryoboxes, it supplies the who’s-who of pharma, CROs, and even Patanjali. But here’s the kicker – Q1 FY26 profits fell 55%, debt climbed to ₹339 Cr, and yet the stock still struts around with a P/E of 60. Either labware has suddenly become haute couture, or investors love pain.


2. Introduction

Welcome to the world where test tubes are big business. Tarsons is not selling chai or steel, it’s selling the unsung heroes of every lab – centrifuge tubes, cryovials, and PCR consumables. You never see them in the headlines, but without them, your favorite pharma stock wouldn’t have a vaccine to brag about.

The company has a diversified portfolio – 55% consumables (use and throw), 40% reusables (wash and repeat), and 5% benchtop equipment (the “tech toys” corner). It has expanded to 40+ countries, bagged brands like Maxipense and Cryochill, and even acquired a German distributor (Nerbe) for European credibility.

But beneath the sterile white packaging lies a messy financial reality: operating margins shrunk from 51% to 29% in two years, PAT growth is negative, and inventory days are longer than your average Indian court case. On paper, Tarsons looks like a global labware giant in the making. On P&L, it looks like a patient on IV drip.


3. Business Model – WTF Do They Even Do?

Tarsons is basically the “Amazon Basics” of labs – they make, brand, and distribute essential labware used by scientists, pharma companies, and diagnostic labs. Their customers range from Lupin and Sun Pharma to Nestle and Himalaya.

The business has three flavors:

  • Consumables (55% revenue): Pipette tips, centrifuge tubes, PCR consumables. Think disposable masks, but for labs. Volume-driven, predictable.
  • Reusables (40%): Bottles, carboys, beakers – the crockery section of a lab. These live longer, so margins differ.
  • Others (5%): Benchtop toys like vortex mixers and centrifuges. Small revenue, but helps Tarsons look cool at exhibitions.

Geography split? 70% domestic, 30% exports. Product split? 35% branded (flashy), 65% ODM (white-label for global giants). So essentially, Tarsons is the secret supplier behind brands you’ve never heard of, but probably used indirectly in a blood test.


4. Financials Overview

MetricLatest Qtr (Jun ’25)YoY Qtr (Jun ’24)Prev Qtr (Mar ’25)YoY %QoQ %
Revenue₹91.4 Cr₹84.8 Cr₹112.7 Cr+7.7%-18.9%
EBITDA₹24.7 Cr₹18.8 Cr₹37.0 Cr+31.4%
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!